Mesoblast (MEOBF) Other Accumulated Expenses (2024 - 2026)
Mesoblast's (MEOBF) quarterly Other Accumulated Expenses came in at $7.4 million in Q2 2026, down 31.84% year-over-year from $10.8 million in Q2 2025, and down 33.31% quarter-over-quarter from $11.0 million in Q4 2025.
Analysis
Mesoblast (MEOBF) Other Accumulated Expenses (2024 - 2026) Analysis & Trends
Mesoblast has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $7.4 million for Q2 2026.
- In Q2 2026, Other Accumulated Expenses fell 31.84% year-over-year to $7.4 million; the TTM figure through Jun 2026 stood at $7.4 million (down 31.84% YoY), while the FY2026 annual figure was $7.4 million, down 31.84% from the prior year.
- Other Accumulated Expenses came in at $7.4 million for Q2 2026 at Mesoblast, down from $11.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $11.0 million in Q4 2025 to a low of $7.4 million in Q2 2026.
- Average Other Accumulated Expenses over 3 years is $9.9 million, with a median of $10.7 million recorded in 2024.
- Year-over-year, Other Accumulated Expenses grew 1.63% in 2025 and slumped 31.84% in 2026.
- Over 3 years, Other Accumulated Expenses stood at $10.6 million in 2024, then advanced by 3.86% to $11.0 million in 2025, then tumbled by 33.31% to $7.4 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $7.4 million in Q2 2026, $11.0 million in Q4 2025, and $10.8 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.36 Mn |
| Dec 31, 2025 | 11.03 Mn |
| Jun 30, 2025 | 10.79 Mn |
| Jun 30, 2024 | 10.62 Mn |